Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leyun Pan

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
American Journal of Nuclear Medicine and Molecular Imaging|December 5, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT in prostate cancer local recurrence: impact of early images and parametric analysisChristos Sachpekidis, Leyun Pan, Boris A Hadaschik, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2022
Application of the long axial field-of-view PET/CT with low-dose [<sup>18</sup>F]FDG in melanomaChristos Sachpekidis, Leyun Pan, Annette Kopp-Schneider, et al.
Clinical and Translational Imaging|November 7, 2017
Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic reviewAntonia Dimitrakopoulou-Strauss, Ulrich Ronellenfitsch, Caixia Cheng, et al.
EJNMMI Research|July 31, 2016
Fractal and multifractal analysis of PET/CT images of metastatic melanoma before and after treatment with ipilimumabChristina-Marina Breki, Antonia Dimitrakopoulou-Strauss, Jessica Hassel, et al.
American Journal of Nuclear Medicine and Molecular Imaging|October 12, 2013
Dynamic PET with (18)F-Deoxyglucose (FDG) and quantitative assessment with a two-tissue compartment model reflect the activity of glucose transporters and hexokinases in patients with colorectal tumorsLudwig G Strauss, Dirk Koczan, Sven Klippel, et al.
Cells|May 26, 2019
Multi-Path Dilated Residual Network for Nuclei Segmentation and DetectionEric Ke Wang, Xun Zhang, Leyun Pan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2020
Interim [<sup>18</sup>F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanomaChristos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, et al.
Cancers|October 23, 2021
Fractal and Multifractal Analysis of PET-CT Images for Therapy Assessment of Metastatic Melanoma Patients under PD-1 Inhibitors: A Feasibility StudyAnastasia Kosmou, Christos Sachpekidis, Leyun Pan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokineticsChristos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2008
Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumorsLudwig G Strauss, Dirk Koczan, Sven Klippel, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Nuclear Medicine and Molecular Imaging|December 5, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT in prostate cancer local recurrence: impact of early images and parametric analysisChristos Sachpekidis, Leyun Pan, Boris A Hadaschik, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2022
Application of the long axial field-of-view PET/CT with low-dose [<sup>18</sup>F]FDG in melanomaChristos Sachpekidis, Leyun Pan, Annette Kopp-Schneider, et al.
Clinical and Translational Imaging|November 7, 2017
Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic reviewAntonia Dimitrakopoulou-Strauss, Ulrich Ronellenfitsch, Caixia Cheng, et al.
EJNMMI Research|July 31, 2016
Fractal and multifractal analysis of PET/CT images of metastatic melanoma before and after treatment with ipilimumabChristina-Marina Breki, Antonia Dimitrakopoulou-Strauss, Jessica Hassel, et al.
American Journal of Nuclear Medicine and Molecular Imaging|October 12, 2013
Dynamic PET with (18)F-Deoxyglucose (FDG) and quantitative assessment with a two-tissue compartment model reflect the activity of glucose transporters and hexokinases in patients with colorectal tumorsLudwig G Strauss, Dirk Koczan, Sven Klippel, et al.
Cells|May 26, 2019
Multi-Path Dilated Residual Network for Nuclei Segmentation and DetectionEric Ke Wang, Xun Zhang, Leyun Pan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2020
Interim [<sup>18</sup>F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanomaChristos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, et al.
Cancers|October 23, 2021
Fractal and Multifractal Analysis of PET-CT Images for Therapy Assessment of Metastatic Melanoma Patients under PD-1 Inhibitors: A Feasibility StudyAnastasia Kosmou, Christos Sachpekidis, Leyun Pan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokineticsChristos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2008
Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumorsLudwig G Strauss, Dirk Koczan, Sven Klippel, et al.
Pageof 6